Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.6873
-0.0090 (-1.29%)
At close: Oct 8, 2025, 4:00 PM EDT
0.6600
-0.0273 (-3.97%)
After-hours: Oct 8, 2025, 7:42 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $2.23 million as of October 8, 2025. Its market cap has decreased by -47.35% in one year.
Market Cap
2.23M
Enterprise Value
-518.77K
1-Year Change
-47.35%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $2.23M, a decrease of -99.98%. That is a compound annual growth rate of -83.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 2.26M | -37.98% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |